$7.04 Billion is the total value of Avoro Capital Advisors LLC's 46 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 37.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | IMMUNOMEDICS INC | $2,232,038,000 | +139.9% | 26,250,000 | 0.0% | 31.71% | +72.4% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $721,155,000 | +47.3% | 4,343,000 | +1.3% | 10.25% | +5.9% |
| HZNP | Buy | HORIZON THERAPEUTICS PLC | $594,252,000 | +78.2% | 7,650,000 | +27.5% | 8.44% | +28.1% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $313,926,000 | +10.4% | 9,536,039 | -8.0% | 4.46% | -20.7% |
| ASND | Buy | ASCENDIS PHARMAsponsored adr | $277,776,000 | +7.3% | 1,800,000 | +2.9% | 3.95% | -22.9% |
| MYOK | Buy | MYOKARDIA INC | $256,982,000 | +41.5% | 1,885,000 | +0.3% | 3.65% | +1.7% |
| ARGX | Sell | ARGENX SEsponsored adr | $236,924,000 | +8.4% | 902,500 | -7.0% | 3.37% | -22.1% |
| SRPT | SAREPTA THERAPEUTICS INC | $235,220,000 | -12.4% | 1,675,000 | 0.0% | 3.34% | -37.1% | |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $231,849,000 | +287.7% | 3,100,000 | +226.3% | 3.29% | +178.7% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $153,202,000 | -7.6% | 10,850,000 | -1.4% | 2.18% | -33.6% |
| XLRN | Buy | ACCELERON PHARMA INC | $151,916,000 | +53.3% | 1,350,000 | +29.8% | 2.16% | +10.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $133,140,000 | -41.7% | 1,750,000 | -5.4% | 1.89% | -58.1% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $126,616,000 | -16.8% | 6,800,000 | +4.6% | 1.80% | -40.2% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $105,670,000 | +166.6% | 890,000 | +154.3% | 1.50% | +91.5% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS INC | $93,366,000 | -15.9% | 1,820,000 | -2.2% | 1.33% | -39.6% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponsored adr | $87,780,000 | -12.3% | 11,000,000 | +10.0% | 1.25% | -37.0% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $87,600,000 | -33.9% | 6,000,000 | -14.3% | 1.24% | -52.5% |
| CNST | Buy | CONSTELLATION PHARMACEUTICALS INC | $86,612,000 | -27.9% | 4,275,000 | +6.9% | 1.23% | -48.2% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $82,400,000 | -48.0% | 8,000,000 | +5.5% | 1.17% | -62.6% |
| Buy | TRILLIUM THERAPEUTICS INC | $78,155,000 | +103.4% | 5,500,000 | +15.8% | 1.11% | +46.1% | |
| KURA | Buy | KURA ONCOLOGY INC | $74,608,000 | +335.9% | 2,435,000 | +131.9% | 1.06% | +213.6% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $74,572,000 | +307.0% | 10,300,000 | +96.2% | 1.06% | +192.5% |
| QURE | Buy | UNIQURE NV | $64,453,000 | -4.6% | 1,750,000 | +16.7% | 0.92% | -31.4% |
| PMVP | New | PMV PHARMACEUTICALS INC | $57,578,000 | – | 1,850,000 | +100.0% | 0.82% | – |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $56,430,000 | -11.5% | 1,500,000 | +5.3% | 0.80% | -36.4% |
| ISEE | Buy | IVERIC BIO INC | $40,890,000 | +12.9% | 7,250,000 | +2.1% | 0.58% | -18.9% |
| ATNX | Sell | ATHENEX INC | $39,507,000 | -25.4% | 3,265,000 | -15.2% | 0.56% | -46.4% |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $38,550,000 | +26.9% | 3,000,000 | -74.9% | 0.55% | -8.8% |
| XENE | XENON PHARMACEUTICALS INC | $30,996,000 | -11.7% | 2,800,000 | 0.0% | 0.44% | -36.6% | |
| CUE | CUE BIOPHARMA INC | $28,144,000 | -38.6% | 1,870,000 | 0.0% | 0.40% | -55.8% | |
| ALT | New | ALTIMMUNE INC | $26,400,000 | – | 2,000,000 | +100.0% | 0.38% | – |
| AMRN | Buy | AMARIN CORP PLCsponsored adr | $25,260,000 | +82.5% | 6,000,000 | +200.0% | 0.36% | +31.0% |
| RTRX | Buy | RETROPHIN INC | $24,460,000 | +14.1% | 1,325,000 | +26.2% | 0.35% | -17.9% |
| RLAY | New | RELAY THERAPEUTICS INC | $21,295,000 | – | 500,000 | +100.0% | 0.30% | – |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $21,168,000 | -42.6% | 4,200,000 | -8.0% | 0.30% | -58.7% |
| RAPT | New | RAPT THERAPEUTICS INC | $18,515,000 | – | 575,000 | +100.0% | 0.26% | – |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS INC | $18,214,000 | -17.7% | 602,500 | +14.8% | 0.26% | -40.9% |
| ZGNX | Sell | ZOGENIX INC | $15,689,000 | -74.2% | 875,000 | -61.1% | 0.22% | -81.4% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $15,342,000 | -7.2% | 545,000 | -6.8% | 0.22% | -33.3% |
| RACA | New | THERAPEUTICS ACQUISITION CORP | $14,380,000 | – | 1,000,000 | +100.0% | 0.20% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $11,643,000 | – | 5,084,184 | +100.0% | 0.16% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $11,348,000 | – | 460,000 | +100.0% | 0.16% | – |
| FENC | FENNEC PHARMACEUTICALS INC | $10,120,000 | -27.4% | 1,670,000 | 0.0% | 0.14% | -47.8% | |
| BCTG | New | BCTG ACQUISITION CORP | $8,672,000 | – | 800,000 | +100.0% | 0.12% | – |
| ALIMERA SCIENCES INC | $2,022,000 | -22.9% | 415,999 | 0.0% | 0.03% | -44.2% | ||
| KYMR | New | KYMERA THERAPEUTICS INC | $1,596,000 | – | 49,400 | +100.0% | 0.02% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL | $0 | – | -2,034,900 | -100.0% | -0.18% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -304,000 | -100.0% | -0.19% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -600,000 | -100.0% | -0.33% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -324,750 | -100.0% | -0.33% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -1,670,000 | -100.0% | -0.54% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -1,128,594 | -100.0% | -0.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.